A.R.T. Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

A.R.T. Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-36,840	Closed	-$276K	–	1677
2019 Q2	$276K	Buy	+36,840	New	+$290K	0.02%	992
2018 Q3	–	Sell	-75,350	Closed	-$485K	–	1646
2018 Q2	$485K	Buy	+75,350	New	+$475K	0.02%	934
2017 Q2	–	Sell	-86,350	Closed	-$693K	–	1667
2017 Q1	$693K	Buy	+86,350	New	+$746K	0.03%	687
2015 Q3	–	Sell	-191,950	Closed	-$2.12M	–	1548
2015 Q2	$2.12M	Buy	191,950 +135,940	+243%	+$1.5M	0.07%	420
2015 Q1	$639K	Buy	+56,010	New	+$594K	0.02%	827
2014 Q3	–	Sell	-128,605	Closed	-$1.11M	–	1492
2014 Q2	$1.11M	Buy	128,605 +62,650	+95%	+$527K	0.06%	465
2014 Q1	$579K	Buy	+65,955	New	+$574K	0.03%	700

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

A.R.T. Advisors's RDY Position: Q3 2019 in Review

A.R.T. Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 36,840 shares — an estimated $276K sold.

A.R.T. Advisors first reported a position in RDY in Q1 2014 and held it in 7 quarters. The position peaked at $2.12M in Q2 2015. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

A.R.T. Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 36,840 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $276K.
A.R.T. Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 7 quarters.
A.R.T. Advisors's Dr. Reddy's Laboratories position peaked at $2.12M in Q2 2015.
152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.